Subarachnoid Administration of Levobupivacaine for Cesarean Section

• Status: Unknown status
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of the investigators study is to compare the clinical effects and side-effects of these three local anaesthetics as sole agents or with the supplementation with fentanyl for c-section, especially when administered in doses achieving approximately an ED 50.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Patras
• Treatments: Bupivacaine; Fentanyl; Levobupivacaine; Ropivacaine

Criteria

Inclusion Criteria:

• Parturients scheduled for elective c section

• Stillborn

• Normal cardiotocogram

Exclusion Criteria:

• BMI>35kg/m2

• Height <150cm or >185cm

• Age (<18, >40)

• ASA > II

• Multiple gestation

• Pregnancy complications (eclampsia, GDP, placenta previa, >2 previous c section)

• Contraindication to spinal anaesthesia

• Failure to educate the patient, language barrier

• Patient preferred GA